Dean Foate of Plexus Corp. (PLXS) sells trust shares, RSUs vest

Rhea-AI Filing Summary

Plexus Corp. Chairman of the Board Dean A. Foate reported insider equity transactions involving common stock and restricted stock units. On February 2, 2026, a trust for which he serves as trustee sold 5,000 Plexus common shares at an average price of $204.8935, leaving 15,000 shares held indirectly by the trust.

On February 3, 2026, 1,370 restricted stock units granted under the Plexus Corp. 2024 Omnibus Incentive Plan vested and settled into 1,370 shares of common stock at an exercise price of $0, increasing his directly held common stock to 109,429 shares and reducing his restricted stock unit balance to zero.

Insider Trade Summary

Net Seller: 5,000 shares ($1,024,468)

Net Sell 3 txns

Insider FOATE DEAN A

Role Director

Sold 5,000 shs ($1.02M)

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	1,370	$0.00	--
Exercise	Common Stock, $.01 par value	1,370	$0.00	--
Sale	Common Stock, $.01 par value	5,000	$204.8935	$1.02M

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock, $.01 par value — 109,429 shares (Direct); Common Stock, $.01 par value — 15,000 shares (Indirect, Trust)

Footnotes (1)

1. Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FOATE DEAN A

(Last) (First) (Middle)

ONE PLEXUS WAY

(Street)

NEENAH WI 54956

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PLEXUS CORP [ PLXS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Chairman of the Board

3. Date of Earliest Transaction (Month/Day/Year)
02/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 par value	02/02/2026		S		5,000	D	$204.8935	15,000	I	Trust(1)
Common Stock, $.01 par value	02/03/2026		M		1,370	A	(2)	109,429	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	02/03/2026		M			1,370	(2)	(2)	Common Stock, $.01 par value	1,370	(2)	0	D

Explanation of Responses:

1. Shares of Plexus Corp. common stock held in a trust for which the reporting person is a trustee.

2. Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. The Restricted Stock Units vested and settled on February 3, 2026.

Remarks:

	/s/ Dean A. Foate, by Kate A. Gitter, Attorney-in-Fact	02/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Dean A. Foate report for Plexus Corp (PLXS)?

Dean A. Foate reported a trust-related sale of 5,000 Plexus Corp. common shares and the vesting of 1,370 restricted stock units into common stock. These transactions adjusted his indirect trust holdings and increased his directly held Plexus common stock balance.

How many Plexus Corp (PLXS) shares were sold in the trust transaction?

A trust associated with Dean A. Foate sold 5,000 Plexus Corp. common shares at an average price of $204.8935 per share. After this sale, the trust continued to hold 15,000 Plexus common shares indirectly attributable to him as trustee.

What happened to Dean A. Foate’s restricted stock units in Plexus Corp (PLXS)?

On February 3, 2026, 1,370 restricted stock units granted under the 2024 Omnibus Incentive Plan vested and settled into 1,370 Plexus common shares. Following this vesting, his restricted stock unit balance fell to zero while his directly held common shares increased.

How many Plexus Corp (PLXS) shares does Dean A. Foate hold directly after these transactions?

After the February 3, 2026 vesting and settlement of 1,370 restricted stock units, Dean A. Foate held 109,429 Plexus Corp. common shares directly. This increase reflects the conversion of his restricted stock units into freely held common stock.

What is the nature of the trust holdings reported for Plexus Corp (PLXS)?

The 5,000-share sale and remaining 15,000 Plexus Corp. shares are held in a trust for which Dean A. Foate serves as trustee. These shares are reported as indirectly owned, reflecting the trust’s ownership rather than direct personal shareholding.

Under which plan did the Plexus Corp (PLXS) restricted stock units vest for Dean A. Foate?

The 1,370 restricted stock units vested under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3. Each unit represented a contingent right to receive one share of Plexus common stock upon vesting and settlement.